Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
10K
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
31.2M
-
Shares change
-
+1.69M
-
Total reported value, excl. options
-
$841M
-
Value change
-
+$47.3M
-
Number of buys
-
39
-
Number of sells
-
-42
-
Price
-
$27.00
Significant Holders of iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q3 2021
94 filings reported holding ITOS - iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q3 2021.
iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.2M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.42M shares), BOXER CAPITAL, LLC (4.35M shares), MPM ASSET MANAGEMENT LLC (3.29M shares), RTW INVESTMENTS, LP (2.35M shares), BioImpact Capital LLC (2.11M shares), BlackRock Inc. (1.56M shares), ALLIANCEBERNSTEIN L.P. (1.34M shares), EcoR1 Capital, LLC (1.3M shares), Artal Group S.A. (994K shares), and Rubric Capital Management LP (989K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.